Mutations or loss of DDX3X are known in DLBCL, Burkitt’s lymphoma, cutaneous T-cell lymphoma, and NK/T-cell lymphoma [27–30]. Here, DDX3X is linked to primary cutaneous T-cell non-Hodgkin lymphoma.